|
Dr. Fernandez joined the pharmaceutical industry in 1979 and has managed international clinical research groups for American Cyanamid, Wyeth-Ayerst, the Wellcome Foundation, and Bayer Biologicals. Originally trained in Internal Medicine and oncology, he has been instrumental in the clinical development and market support of numerous compounds across a wide range of therapeutic areas, including anticancer, infectious diseases, respiratory, and neurology. He is currently responsible for the worldwide medical and scientific affairs group. | 